RESULTS study now, compliance, and adverse effe
one hundred and fifty subjects were enrolled in the study, and I46 completed the intervention between June and September 2013. One and three subjects withdrew from the CRTE and placebo groups. respectively, Treatment compliance was similar in both study arms. An average of 6.2a2 1 capsules was returned in the CRTE arm and an average of 6.6t2.6 capsules was retumed in the placebo arm. cRTE was safe and well tolerated. No serious AEs occurred during the study. None of the subjects in the CRTE ann were discontinued from the study due to AEs, and none of the AEs led to an intervention or any significant additional concomitant therapy. No significant laboratory abnormalities or clinically ported during the study significant changes in vital signs or physical findings were re Baseline characteristics of participants Mean age of participants was 34 8tli and 34.9t 4 years in the CRTE and placebo groups, pectively. Fem represented 5 of the cRTE group and S5,4% of the placebo group. Mean BMI was 22442.2 and 22.5 2,2 kg/m2 and mean waist circumference was 81.9t7.6 and 81.9t8.6 cm in CRTE and placebo groups, respectively.